North Carolina State University, the University of North Carolina and Duke University together spent more than $1 million lobbying the federal government this year, according to a report by The Business Journals drawing on disclosure filings.

The three institutions, anchors of the Research Triangle, each registered federal advocacy activity and reported their spending through the disclosure system that Congress requires. The combined total crosses the seven-figure mark for the year.

For R&D managers at the universities and their industry partners, the lobbying spend signals how much of the Triangle's research enterprise now depends on decisions made in Washington — appropriations for federal science agencies, policy on indirect-cost reimbursement, and oversight of research security rules.

What did the universities want?

The Business Journals reviewed what the three schools were seeking from federal policymakers during the period covered by the disclosures. The report ties each institution's advocacy to its specific agenda before Congress and executive-branch agencies.

Lobbying disclosure filings list the issues on which each institution engaged. Universities of this scale typically lobby on research funding, tax provisions affecting endowments and student aid, but the specific asks reported by The Business Journals define this year's priorities for the three schools.

Why does the spending matter for research budgets?

A combined $1 million-plus outlay from three universities in a single state in a single year is a concrete measure of institutional priority. That money comes out of central budgets at a time when university leaders across the sector are weighing flat federal research appropriations, tighter caps on facilities-and-administrative reimbursements, and growing compliance costs tied to export-control and research-security mandates.

The Triangle institutions compete for grants from the National Institutes of Health, the National Science Foundation, the Department of Energy and the Department of Defense. Advocacy in Washington aims to protect and expand those funding channels before annual appropriations bills are finalized.

For corporate R&D leaders sited near the universities, the lobbying posture is a leading indicator of where the institutions expect federal research dollars — and where they anticipate friction, whether in cost-recovery rules or in scrutiny of international research collaborations.

What happens next?

Disclosure filings update on a rolling basis, and the next cycle of reports will show whether the three universities hold, raise or cut their advocacy budgets as the appropriations season and policy debates in Washington play out.